![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MP Lawton, T Kronbach, EF Johnson and RM Philpot
Laboratory of Cellular and Molecular Pharmacology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.
Our laboratory recently isolated and sequenced cDNAs encoding the microsomal flavin-containing monooxygenases (FMOs) from rabbit liver and rabbit lung. As a first step in understanding the molecular bases for the catalytic and physical differences between these enzymes, we have expressed them in COS-1 cells and compared the properties of the recombinant and native microsomal proteins. Microsomes from transfected cells were examined immunochemically by immunoblotting and catalytically by following methimazole oxidation in the presence and absence of various modulators. The expressed and native FMOs have the same mobilities in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and the same responses to pH, sodium cholate, magnesium, and temperature, all of which serve to differentiate between the lung and liver enzymes. Analysis of methimazole metabolism in microsomes isolated from rabbit liver or lung showed biphasic kinetics, indicative of two or more enzymes taking part in the reaction. In contrast, the kinetics of methimazole oxidation catalyzed by the expressed FMOs were clearly linear and matched one of the phases observed with the native preparations. Chlorpromazine and imipramine, which are not substrates for the pulmonary FMO, were found to be competitive inhibitors of the high affinity reaction in pulmonary microsomes. These results, and others, indicate that both rabbit lung and liver contain more than one form of FMO.
This article has been cited by other articles:
|
|
 |
|
  V. Lattard, C. Longin-Sauvageon, and E. Benoit Cloning, Sequencing and Tissue Distribution of Rat Flavin-Containing Monooxygenase 4: Two Different Forms Are Produced by Tissue-Specific Alternative Splicing Mol. Pharmacol., January 1, 2003; 63(1): 253 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Krueger, S. R. Martin, M.-F. Yueh, C. B. Pereira, and D. E. Williams Identification of Active Flavin-Containing Monooxygenase Isoform 2 in Human Lung and Characterization of Expressed Protein Drug Metab. Dispos., January 1, 2002; 30(1): 34 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Krueger, M.-F. Yueh, S. R. Martin, C. B. Pereira, and D. E. Williams Characterization of Expressed Full-Length and Truncated FMO2 from Rhesus Monkey Drug Metab. Dispos., April 13, 2001; 29(5): 693 - 700. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Halpert, T. L. Domanski, O. Adali, C. P. Biagini, J. Cosme, E. A. Dierks, E. F. Johnson, J. P. Jones, P. O. de Montellano, R. M. Philpot, et al. Structure-Function of Cytochromes P450 and Flavin-Containing Monooxygenases. Implications for Drug Metabolism Drug Metab. Dispos., December 1, 1998; 26(12): 1223 - 1231. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. T. Dolphin, D. J. Beckett, A. Janmohamed, T. E. Cullingford, R. L. Smith, E. A. Shephard, and I. R. Phillips The Flavin-containing Monooxygenase 2 Gene (FMO2) of Humans, but Not of Other Primates, Encodes a Truncated, Nonfunctional Protein J. Biol. Chem., November 13, 1998; 273(46): 30599 - 30607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Itagaki, G. T. Carver, and R. M. Philpot Expression and Characterization of a Modified Flavin-containing Monooxygenase 4from Humans J. Biol. Chem., August 16, 1996; 271(33): 20102 - 20107. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
